The Crisp Trial: An RCT of Risk Assessment and Decision Support to Implement Risk-Stratified Colorectal Cancer Screening in Primary Care.

Grant number: 1121104 | Funding period: 2017 - 2020

Completed

Abstract

There is a mismatch between people’s use of bowel cancer screening tests through faecal occult blood testing or colonoscopy and their individual risk of bowel cancer. Building on the work of our NHMRC Centre for Research Excellence (CRE) on Optimising Colorectal Cancer Screening, this trial will test the effect of an electronic risk assessment tool, implemented in general practice, on use of the most appropriate screening test for bowel cancer based on a person’s risk of developing the condition

Related publications (2)

The Colorectal cancer RISk Prediction (CRISP) trial: a randomised controlled trial of a decision support tool for risk-stratified colorectal cancer screening

JD Emery, MA Jenkins, S Saya, P Chondros, J Oberoi, S Milton, K Novy, E Habgood, N Karnchanachari, M Pirotta, L Trevena, A Bickerstaffe, R De Abreu Lourenço, A Crothers, DA Ouakrim, L Flander, JG Dowty, FM Walter, M Clark, S Doncovio

2023-08-01

Background A risk-stratified approach to colorectal cancer (CRC) screening could result in a more acceptable balance of benefits a..

The use of a risk assessment and decision support tool (CRISP) compared with usual care in general practice to increase risk-stratified colorectal cancer screening: Study protocol for a randomised controlled trial

JG Walker, F Macrae, I Winship, J Oberoi, S Saya, S Milton, A Bickerstaffe, JG Dowty, R De Abreu Lourenço, M Clark, L Galloway, G Fishman, FM Walter, L Flander, P Chondros, D Ait Ouakrim, M Pirotta, L Trevena, MA Jenkins, JD Emery

2018-07-25

Background: Australia and New Zealand have the highest incidence rates of colorectal cancer worldwide. In Australia there is signi..

University of Melbourne Researchers